Cellcentric Ltd.
Clinical trials sponsored by Cellcentric Ltd., explained in plain language.
-
New hope for blood cancer patients: experimental drug CCS1477 enters human trials
Disease control Recruiting nowThis study tests a new drug called CCS1477 (inobrodib) in people with advanced blood cancers like leukemia, lymphoma, and myeloma that have not responded to standard treatments. The drug is given as an oral capsule, either alone or combined with other cancer medicines. The goal i…
Phase: PHASE1, PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for hard-to-treat myeloma: experimental combo targets relapsed patients
Disease control Recruiting nowThis study tests a new drug, inobrodib, combined with two standard medicines (pomalidomide and dexamethasone) in 100 adults whose multiple myeloma has come back or no longer responds to available therapies. The goal is to see how well the combination shrinks tumors and to learn m…
Phase: PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC